Regarding baseline total and H-specific GDF15 levels, total GDF15 was similar between MASLD patients and controls (776.1 ± 296.4 vs. 581.5 ± 230.6 pg/mL, p = 0.09). Here, GDF15 is linked to metabolic dysfunction-associated steatotic liver disease.